Prostate Cancer Ontology
Center for Systems Biology, Sichuan University West China Hospital, Sichuan China
跳过导航链接。
折叠 Prostate cancerProstate cancer
展开 Epidemiological aspects of prostate cancerEpidemiological aspects of prostate cancer
展开 Diagnostic aspects of prostate cancerDiagnostic aspects of prostate cancer
折叠 Therapeutic aspects of prostate cancerTherapeutic aspects of prostate cancer
展开 Deferred treatmentDeferred treatment
展开 SurgerySurgery
展开 RadiotherapyRadiotherapy
展开 CryotherapyCryotherapy
展开 Hormonal therapyHormonal therapy
展开 ChemotherapyChemotherapy
展开 Castration-resistant prostate cancer (CRPC)Castration-resistant prostate cancer (CRPC)
展开 Metastatic prostate cancerMetastatic prostate cancer
折叠 Other treatmentOther treatment
展开 Management of prostate cancer in older menManagement of prostate cancer in older men
展开 Options other than surgery and radiotherapy for the primary treatment of localised prostate cancerOptions other than surgery and radiotherapy for the primary treatment of localised prostate cancer
折叠 Post-treatment quality of life in patients with localised prostate cancerPost-treatment quality of life in patients with localised prostate cancer
展开 Treatment of PSA-only recurrence after treatment with curative intentTreatment of PSA-only recurrence after treatment with curative intent
Non-metastatic bone fractures
Preferred Name Non-metastatic bone fractures
Definition Due to increased bone turnover and decreased BMD in a time-dependent manner, ADT use is linked to an increased risk of fracture (up to 45% relative risk with long-term ADT). Hip fractures in men are associated with a significant risk of death. A precise evaluation of BMD should be performed by dual emission X-ray absorptiometry (DEXA) before starting long-term ADT. An initial low BMD (T-score < -2.5 or < -1, with other risk factors) indicates a high risk of subsequent non-metastatic fracture. The WHO FRAX tool (http://www.shef.ac.uk/FRAX) should be used to evaluate individual risk. Obesity (increase in body fat mass by up to 10%) and sarcopenia (decrease in lean tissue mass by up to 3%) are common and occur during the first year of ADT. Both changes increase the fracture risk.
Synonyms & Abbreviations Non-metastatic bone fractures
ReferenceCode NA
ReferenceURL NA
PMID NA
Copyright (C) 2022 Institutes for Systems Genetics, Sichuan University West China Hospital. All Rights Reserved.